<DOC>
	<DOC>NCT00132119</DOC>
	<brief_summary>The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling.</brief_summary>
	<brief_title>Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling</brief_title>
	<detailed_description>Randomized, double-blind, placebo-controlled, parallel-group, multi-centered, outpatient study to assess the efficacy, safety and tolerability of two doses of nalmefene in patients with current diagnosis of pathological gambling.</detailed_description>
	<mesh_term>Gambling</mesh_term>
	<mesh_term>Nalmefene</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Current diagnosis of pathological gambling as defined by Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSMIVTR)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>